
Nicklaus: Promising arthritis drug is a win for St. Louis' biotech strategy
When shares of Pennsylvania-based Aclaris Therapeutics rocketed upward last week, the credit belonged to a drug developed in a St. Louis laboratory. Aclaris said Jan. 19 that its arthritis pill, known as ATI-450, appeared safe and effective in a small …